The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery

Journal of Clinical Immunology

Volumn 22, Issue 5, 2002, Pages 289-296

  Slotwiński, Robert ^a   Olszewski, Waldemar L ^a   Chaber, Andrzej ^b   Slodkowski, Maciej ^b   Zaleska, Marzanna ^a   Krasnodebski, Ireneusz W ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Colorectal surgery; Systemic cytokine production

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; COLORECTAL SURGERY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; INFECTIOUS COMPLICATION; INFLAMMATION; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; SEPSIS;

ANTIGENS, CD; BIOLOGICAL MARKERS; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; CYTOKINES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; POSTOPERATIVE COMPLICATIONS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 0036749660     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020022006043     Document Type: Article

References (42)

1. Tang R, Chen HH, Wang YL, Changchien CR, Chen JS, Hsu KC, Chiang JM, Wang JY: Risk factors for surgical site infection after elective resection of colon and rectum: A single-center prospective study of 2,809 consecutive patients. Ann Surg 234:181-189, 2001
2. Fielding LP, Stewart-Brown S, Blesovsky L, Kearney G: Anastomotic integrity after operations for large-bowel cancer: A multicentre study. BMJ 281:411-414, 1980
3. Napolitano LM, Faist E, Wichmann MW, Coimbra R: Immune dysfunction in trauma. Surg Clin N Am 79:1385-1416, 1999
4. Bone R: Immunologic dissonance: A continuing evolution in our understanding of systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 125:680-687, 1996
5. Kuntz C, Wunsch A, Bay F, Windeler J, Glaser F, Herfarth C: Prospective randomized study of stress and immune response after laparoscopic versus conventional colorectal resection. Surg Edosc 12:963-967, 1998
6. Hewitt PM, Ip SM, Kwok SPY, Spmers SS, Li K, Leung KL, Li AKC: Laparoscopic-assisted versus open surgery for colorectal cancer. Comparative study of immune effects. Dis Colon Rectum 41:901-909, 1998
7. Harmon GD, Senagore AJ, Kilbride MJ, Warzyński MJ: Interleukin 6 response to laparoscopic and open colectomy. Dis Colon Rectum 37:754-759, 1994
8. Stage JG, Schulze S, Moller P, Overgaard H, Andersen M, Rebsdorf-Pedersen VB, Nielsen HJ: Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Br J Surg 84:391-396, 1997
9. Schwenk W, Jacobi C, Mansmann U: Inflammatory response after laparoscopic and conventional colorectal resections-Results of prospective, randomized trial. Langebeck's Archiv Surg 385:2-9, 2000
10. Gurleyik E, Gurleyik G, Centinkaya F: The inflammatory response to open tension-free inguinal hernioplasty versus conventional repairs. Am J Surg 175:179-182, 1998
11. Grzelak I, Olszewski WL, Zaleska M, Durlik M, Lagiewska B, Muszyński M, Rowiński W: Blood cytokine levels rise even after minor surgical trauma. J Clin Immunol 16:159-164, 1996
12. Gupta A, Watson DI: Effect of laparoscopy on immune function. Br J Surg 88:1296-1306, 2001
13. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as marker of severity. Ann Surg 215:356-362, 1992
14. Waage A, Halstensen A, Espevik T: Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1:355-357, 1987
15. Kasai T, Inada K, Takakuwa T: Anti-inflammatory cytokine levels in patients with septic shock. Res Com Mol Pathol Pharm 98:34-42, 1997
16. Charalambos Gogos A, Drossou E, Bassaris HP: Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181:176-180, 2000
17. Pruitt JH, Welborn MB, Edwards PD, Harward TR, Seeger JW, Martin TD, Smith C, Kenney JA, Wesdorp RI, Meijer S, Cuesta MA, Abouhanze A, Copeland EM, Giri J, Sims JE, Moldawer LL, Oldenburg HS: Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282-3288, 1996
18. Partrick DA, Moore EE, Moore FA, Biffi WL, Barnett CC: Release of anti-inflammatory mediators after major torso trauma correlates with the development of postinjury multiple organ failure. Am J Surg 178:564-569, 1999
19. Cinat M, Waxman K, Vaziri ND: Soluble cytokine receptors and receptors antagonists are sequentially released after trauma. J Trauma 39:112-117, 1995
20. O'Nuallain EM, Puri P, Meely K: Induction of interleukin-1 receptor antagonist (Il-1ra) following surgery is associated with major trauma. Clin Immunol Immunopathol 76:96-101, 1995
21. Keel M, Ecknauer E, Stocker R, Ungethum U, Steckholzer U, Kenney J, Gallati H, Trentz O, Ertel W: Different pattern of local and systemic release of proinflammatory and anti-inflammatory mediators in severely injured patients with chest trauma. J Trauma 40:907-912, 1996
22. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975-978, 1989
23. Strieter RM, Kunkel SL, Bone RC: Role of tumor necrosis factor-α in disease states and inflammation Crit Care Med 21:S447-S463, 1993
24. O'Nuallain EM, Puri P, Reen DJ: Early induction of Il-1 receptor antagonist (Il-1ra) in infants and children undergoing surgery. Clin Exp Immunol 93:218-222, 1993
25. Tan LR, Waxman K, Scannell G, Ioli G, Granger GA: Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma 34:634-638, 1993
26. Rabinovici R, John R, Esser KM, Vernick J, Feuerstein G: Serum tumor necrosis factor-alpha profile in trauma patients. J Trauma 35:698-702, 1993
27. Shenkin a, Fraser WD, Series J, Winstanley FP, McCartney AC, Burns HJ, Van Damme J: The serum interleukin 6 response to elective surgery. Lymphokine Res 8:123-127, 1989
28. Cruickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A: Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Colch) 79:161-165, 1990
29. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ: Systemic cytokine response after major surgery. Br J Surg 79:757-760, 1992
30. Kimura F, Miyazaki M, Suwa T: Plasma concentrations of cytokine antagonists in patients with infection following liver resection. Br J Surg 85:1631-1635, 1998
31. Klava A, Windsor AC, Farmery SM, Woodhouse LF, Reynolds JV, Ramsden CW, Boylston AW, Guillou PJ: Interleukin-10 role in development of postoperative immunosuppression. Arch Surg 132:425-429, 1997
32. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F: Gender differences in human sepsis. Arch Surg 133:1200-1205, 1998
33. Ohara RJ, Greenman J, MacDonald AW, Gaskell KM, Toppig KP, Duthie GS, Kerin MJ, Lee PW, Monson JR: Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production. Clin Cancer Res 4:1943-1948, 1998
34. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of human interleukin-1 receptor antagonist. Nature 343:341, 1990
35. Hannum CH, Wilcox CJ, Arend WP. Joslin FG, Dripps DJ, Heidal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340, 1990
36. Fischer E, Morano MA, Van Zee KJ, Marano MA, Rock CS, Hawes AS, Thompson WA, DeForge L, Kenney JS, Remick DC, Bloedow DC: Interleukin-1 receptor blokade improves survival and hemodynamic performance in E. coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 89:1551-1557, 1992.
37. Kuster H, Weiss M, Willeitner A, Detlefsen S, Jeremias I, Zbojan J, Geiger R, Lipowsky G, Simbruner G: Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 352:1271-1277, 1998
38. Fernandez-Botran R: Soluble cytokine receptors: Basic immunology and clinical applications. Crit Rev Clin Lab Sci 36:165-224, 1999
39. Arend WP: Inhibiting the effects of cytokines in human diseases. Adv Intern Med 40:365-394, 1995
40. Sato TA, Widmer MB, Finkelman FD, Madani H, Jacobs CA, Grabstein KH, Maliszewski CR: Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol 150:2717-2723, 1993
41. Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russell DA: Multifunctional regulation of biological effects of TNF-α by soluble type I and II TNF receptors. Cytokine 7:26-38, 1995
42. Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A: Procalcitonin in early detection of postoperative complications. Dig Surg 15:260-265, 1998